Exposed peptide core of IgA1 hinge region in IgA nephropathy

Abstract

Background. The human IgA1 hinge region is a very unique O-linked glycopeptide, and its sialylation and galactosylation recently were reported to be defective in the serum IgA1 derived from patients with IgA nephropathy (IgAN). This study was performed to examine the underglycosylation of the IgA1 hinge region and consequent exposure of the peptide core in IgAN. Methods. A polyclonal antibody against a synthetic human IgA1 hinge peptide, PVPSTPPTPSPSTPPTPSPS, (anti-sHP ab) was raised in rabbits and shown specifically to recognize the IgA1 which was treated with neuraminidase, β-galactosidase and α-N-acetylgalactosaminidase. The reactivity of the anti-sHP ab against the purified serum IgA1 was compared among the following three groups: 39 patients with IgAN, 30 patients with other renal diseases (ORD) and 21 healthy controls (HC) using an enzyme-linked immunosorbent assay. Results. The reactivity was significantly higher in the IgAN group (mean ± SD of OD 490 nm: 0.327 ± 0.059) than in the ORD group (0.274 ± 0.043, P = 0.0002) and in the HC group (0.265 ± 0.037, P < 0.0001). No significant difference was observed between the latter two groups. The frequency of positive cases (> mean + 2SD of HC) was 46.2% (18/39) in the IgAN group, 6.7% (2/30) in the ORD group and 0% (0/21) in the HC group. Conclusions. It was suggested that the peptide core of the IgA1 hinge region is exposed aberrantly by a defective N-acetylgalactosaminylation and plays a possible role in the pathogenesis of IgAN.